Gene doping.
Gene doping abuses the legitimate approach of gene therapy. While gene therapy aims to correct genetic disorders by introducing a foreign gene to replace an existing faulty one or by manipulating existing gene(s) to achieve a therapeutic benefit, gene doping employs the same concepts to bestow performance advantages on athletes over their competitors. Recent developments in genetic engineering have contributed significantly to the progress of gene therapy research and currently numerous clinical trials are underway. Some athletes and their staff are probably watching this progress closely. Any gene that plays a role in muscle development, oxygen delivery to tissues, neuromuscular coordination, or even pain control is considered a candidate for gene dopers. Unfortunately, detecting gene doping is technically very difficult because the transgenic proteins expressed by the introduced genes are similar to their endogenous counterparts. Researchers today are racing the clock because assuring the continued integrity of sports competition depends on their ability to develop effective detection strategies in preparation for the 2012 Olympics, which may mark the appearance of genetically modified athletes.
Azzazy
Hassan M E
HM
Department of Chemistry, SSE # 1194, AUC Avenue, 74, New Cairo, 11835, Egypt. hazzazy@aucegypt.edu
D004300:Doping in Sports / Q000379:methods*; D018014:Gene Transfer Techniques / Q000009:adverse effects; D005822:Genetic Vectors; D006801:Humans; D009124:Muscle Proteins / Q000096:biosynthesis / Q000235:genetics; D014780:Viruses / Q000235:genetics
D009124:Muscle Proteins